WARFARIN Drug Patent Profile
✉ Email this page to a colleague
When do Warfarin patents expire, and what generic alternatives are available?
Warfarin is a drug marketed by Amneal Pharms, Aurobindo Pharma Usa, Barr, Chartwell Rx, Invagen Pharms, Ipca Labs Ltd, Pliva, Taro, Usl Pharma, Watson Labs, and Zydus Pharms Usa. and is included in seventeen NDAs.
The generic ingredient in WARFARIN is warfarin sodium. There are twenty-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Warfarin
A generic version of WARFARIN was approved as warfarin sodium by TARO on July 15th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for WARFARIN?
- What are the global sales for WARFARIN?
- What is Average Wholesale Price for WARFARIN?
Summary for WARFARIN
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 17 |
| Drug Prices: | Drug price information for WARFARIN |
| Drug Sales Revenues: | Drug sales revenues for WARFARIN |
| DailyMed Link: | WARFARIN at DailyMed |
US Patents and Regulatory Information for WARFARIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040301-001 | Jul 15, 1999 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Invagen Pharms | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 090935-005 | May 25, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040196-004 | Sep 30, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
